Using leftover patient samples for research
Part of Blood & lymphatic clinical trials.
This study uses leftover blood, bone marrow, or tissue samples that were already sent to a specific lab (LabPMM) for testing. Researchers want to study these samples to learn more about diseases and improve future tests for patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- Your blood, bone marrow, or tissue sample must have been sent to LabPMM for testing.
- Your sample cannot have come from another company under a material transfer agreement.
- Your sample cannot have been used in a previous clinical study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects and stores tumor and blood samples from children and young adults with cancer, blood disorders, or immune conditions. The samples are used to better understand these diseases and could help future treatments.
This study collects and stores leftover melanoma tissue (and sometimes blood) for future research and testing. If the trial uses your stored samples to help match treatments, it could support better care planning over time.
This trial is a tissue and blood bank that collects samples for future research. You may be asked to give blood and/or tissue again later, but it is meant to be done without interfering with your care.
This trial studies whether analyzing leftover tissue from cancer surgery can help researchers learn more about tumors. It may help improve future diagnosis or treatment by making use of tissue that would otherwise be discarded.
This trial collects tissue, blood, and other body fluid samples from people with blood-related cancers. The goal is to help researchers study these diseases by building a source of samples for future testing.
This study collects and stores leftover or newly taken samples of tissue and blood from people with cancer. The goal is to build a research library that can help investigators study cancer and develop better tests or treatments.
Hear when a new Hematologic Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.